Dibotermin alfa
Term · Oncology and biomedicine · MLC-T-ONC-013039
A recombinant form of human bone morphogenetic protein 2 (rhBMP-2), with potential bone remodeling and osteoinductive activities. Following administration, dibotermin alfa induces signaling cascades, which leads to osteoblast differentiation, enhancement of bone repair and formation, and improvement of re-vascularization. This promotes bone healing. BMP-2, a protein belonging to the transforming growth factor beta (TGFb) superfamily of proteins, plays a key role in bone and cartilage formation.
| Identifier | MLC-T-ONC-013039 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | rhBMP2 |
| Synonyms | diotermin; nebotermin |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013039",
"term": "Dibotermin alfa",
"field": "Oncology and biomedicine",
"definition": "A recombinant form of human bone morphogenetic protein 2 (rhBMP-2), with potential bone remodeling and osteoinductive activities. Following administration, dibotermin alfa induces signaling cascades, which leads to osteoblast differentiation, enhancement of bone repair and formation, and improvement of re-vascularization. This promotes bone healing. BMP-2, a protein belonging to the transforming growth factor beta (TGFb) superfamily of proteins, plays a key role in bone and cartilage formation.",
"abbreviation": "rhBMP2",
"synonyms": [
"diotermin",
"nebotermin"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dibotermin-alfa/"
}
Record 5,955 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.